Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue 6, 2010, Pages 363-369

  Zeman, Kirby L ^a   Wu, Jihong ^a   Bennett, William D ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

deposition; extremely slow inhalation; gamma camera imaging; mucociliary clearance; nebulizers

Indexed keywords

SULFUR; TECHNETIUM 99M;

ADULT; AEROSOL; AIRWAY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; INHALATION; MALE; NEBULIZER; NORMAL HUMAN; PARTICLE SIZE; TIDAL VOLUME;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; BRONCHODILATOR AGENTS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INHALATION; MALE; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; RESPIRATORY FUNCTION TESTS; RESPIRATORY RATE; RESPIRATORY SYSTEM; YOUNG ADULT;

EID: 78649978938     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2008.0711     Document Type: Article

References (23)

1. Gibson RL, Burns JL, and Ramsey BW: Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168:918-951.
2. Durcan N, Murphy C, and Cryan S-A: Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharma-ceut. 2008;5:559-566.
3. Lock R, Collingwood S, and Ratcliffe A: Emerging therapies for respiratory diseases. Drug News Perspect. 2007;20:593-600.
4. Flotte TR, and Laube BL: Gene therapy in cystic fibrosis. Chest. 2001;120:124S-131S.
5. Usmani OS, Biddiscombe, MF, and Barnes PJ: Regional lung deposition and bronchodilator response as a function of B2-Agonist particle size. Am J Respir Crit Care Med. 2005;172: 1497-1504.
6. Mitsakou C, Mitrakos D, Neofytou P, and Housiadas C: A simple mechanistic model of deposition of water-soluble aerosol particles in the mouth and throat. J Aerosol Med. 2007;20:519-529.
7. Anderson M, Philipson K, Svartengren M, and Camner P: Humandeposition and clearanceof6-mm particles inhaled with an extremely low flow rate. Exp. Lung Res. 1995;21:187-195.
8. Anderson M, Svartengren M, Dahlbäck M, Nerbrink O, Philipson K, and Camner P: Human tracheobronchial deposition and effect of two cholinergic aerosols. Exp Lung Res. 1993;19:653-669.
9. Anderson M, Svartengren M, and Camner P: Human tra-cheobronchial deposition and effect of a histamine aerosol inhaled by extremely slow inhalations. J Aerosol Med. 1999; 30:289-297. (Pubitemid 29041528)
10. Camner P, Anderson M, Philipson K, Bailey A, Hashish A, Jarvis N, Bailey M, and Svartengren M: human bronchiolar deposition and rentention of 6-, 8-, and 10-mm particles. Exp Lung Res. 1997;23:517-535. (Pubitemid 27456444)
11. Falk R, Philipson K, Svartengren M, Jarvis N, Bailey M, and Camner P: Clearance of particles from small ciliated airways. Exp Lung Res. 1997;23:495-515.
12. Lindstrom M, Camner P, Falk R, Hjelte L, Philipson K, and Svartengren M: Long-term clearance from small airways in patients with cystic fibrosis. Exp Respir J. 2005;25:317-323. (Pubitemid 40246533)
13. Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, and Sommerer K: Targeting delivery of aerosols to different lung regions. J Aerosol Med. 2002;15:179-188.
14. Lay JC, Clifford BR, Kim SC, and Bennett WD: Retention of insoluble particles after local intrabronchial deposition in dogs. J Appl Physiol. 1995;79:1921-1929.
15. Pitcairn GR, and Newman SP: Tissue attenuation corrections in gamma scintigraphy. J Aerosol Med. 1997;10:187-198.
16. Lippmann M, Yeates DB, and Albert RE: Deposition, retention and clearance of inhaled particles. Br J Indust Med. 1980;37:337-362.
17. Stahlhofen W, Gebhart J, and Heyder J: Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. Am Ind Hyg Ass J. 1980; 41:385-398.
18. Bennett WD, Scheuch G, and Zeman KL: Bronchial airway deposition and retention of particles in inhaled boli: effect of anatomic dead space. J Appl Physiol. 1998;85:685-694.
19. Knudson RJ, Burrows B, and Lebowitz MD: The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. Am Rev Respir Dis. 1976;114:871-879.
20. Usmani OS, Biddiscombe MF, Nightingale JA, Underwood SR. and Barnes PJ: Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol. 2003;95:2106-2112.
21. Weda M, Zanen P, deBoer AH, Barends DM, and Frijlink HW: The therapeutic index of locally acting inhaled drugs as a function of their fine particle mass and particle size distri-bution\a literature review. Curr Drug Deliv. 2008;5:142-147.
22. Clark AR, Chambers CB, Muir D, Newhouse MT, Paboojian S, and Schuler C: The effect of biphasic inhalation profiles on the deposition and clearance of coarse (6.5mm) bolus aerosols. J Aerosol Med. 2007;20:75-82.
23. Smith JRH, Bailey MR, Etherington G, Shutt AL, and Youngman MJ: Effect of particle size on slow particle clearance from the bronchial tree. Exp Lung Res. 2008;34:287-312